S730 Vedolizumab Is Associated With Lower Risk of Clostridioides difficile Infection Compared to Anti-TNF Alpha Agents Among Biologic-Naïve Patients With Ulcerative Colitis
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI